You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay Program
Terms and Conditions
We want to give you the opportunity to share your experience living with low platelet counts in chronic ITP and treatment with Doptelet. Sharing your story can help inform and inspire others. Sounds awesome, right? Scroll down to start!
If you, or someone you care for, is currently on Doptelet and would like to learn more about sharing a story, fill out the form, below, and one of our representatives will get in touch.
IMPORTANT SAFETY INFORMATION
What is DOPTELET® (avatrombopag) [dop-TEL-et]?
DOPTELET is a prescription medicine used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Doptelet is used to help raise platelet counts in adults with chronic ITP, but it is not used to make platelet counts normal in these patients. It is not known if DOPTELET is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Before taking DOPTELET, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DOPTELET may affect the way other medicines work, and other medicines may affect the way DOPTELET works.
What are the possible side effects of DOPTELET?
DOPTELET may cause serious side effects, including blood clots. People with chronic immune thrombocytopenia and people with certain blood clotting conditions may have increased risk of developing blood clots. Tell your healthcare provider right away if you have signs and symptoms of a blood clot, including:
The most common side effects of DOPTELET when used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) are:
These are not all the possible side effects of DOPTELET. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag) [dop-TEL-et]?
What is DOPTELET® (avatrombopag) [dop-TEL-et]?
DOPTELET is a prescription medicine used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough.
Doptelet is used to help raise platelet counts in adults with chronic ITP, but it is not used to make platelet counts normal in these patients. It is not known if DOPTELET is safe and effective in children.
IMPORTANT SAFETY INFORMATION
Before taking DOPTELET, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. DOPTELET may affect the way other medicines work, and other medicines may affect the way DOPTELET works.
What are the possible side effects of DOPTELET?
DOPTELET may cause serious side effects, including blood clots. People with chronic immune thrombocytopenia and people with certain blood clotting conditions may have increased risk of developing blood clots. Tell your healthcare provider right away if you have signs and symptoms of a blood clot, including:
The most common side effects of DOPTELET when used to treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) are:
These are not all the possible side effects of DOPTELET. Call your doctor for medical advice about side effects. You are encouraged to report side effects to FDA at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to use this website, you consent to our use of these cookies. Read more about our
use of cookies